Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Shankar Musunuri [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 5, 2026, Shankar Musunuri, the Chairman of the Board of Directors and Chief Executive Officer of the Company, adopted a Rule 10b5-1 Sales Plan (the "Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Plan provides, during the term commencing on September 9, 2026 and ending on September 9, 2027, for the potential periodic sale of up to 2,188,783 shares of common stock owned by Dr. Musunuri, directly or indirectly, and for the potential sale from time to time of up to 2,802,208 shares of common stock issuable upon the exercise of options granted to Dr. Musunuri.
|
| Name | Shankar Musunuri |
| Title | the Chairman of the Board of Directors and Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 5, 2026 |
| Expiration Date | September 9, 2027 |
| Arrangement Duration | 365 days |
| Dr. Musunuri Rule Trading Arrangement, Common Stock [Member] | Shankar Musunuri [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 2,188,783 |
| Dr. Musunuri Rule Trading Arrangement, Stock Options [Member] | Shankar Musunuri [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 2,802,208 |